IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Eksperimental'naya i Klinicheskaya Farmakologiya

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

0.25

h-Index

2022-2023

 16

Rank

2022-2023

 24566

SJR

2022-2023

 0.116

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Eksperimental'naya i Klinicheskaya Farmakologiya
Abbreviation Eksp. Klin. Farmakol.
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)
h-index 16
Overall Rank/Ranking 24566
SCImago Journal Rank (SJR) 0.116
Impact Score 0.25
Publisher Folium Ltd
Country Russian Federation
ISSN 08692092
Best Quartile Q4
Coverage History 1992-2022




About Eksperimental'naya i Klinicheskaya Farmakologiya


Eksperimental'naya i Klinicheskaya Farmakologiya is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4). It is published by Folium Ltd. The overall rank of Eksperimental'naya i Klinicheskaya Farmakologiya is 24566. According to SCImago Journal Rank (SJR), this journal is ranked 0.116. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 16. The best quartile for this journal is Q4.

The ISSN of Eksperimental'naya i Klinicheskaya Farmakologiya journal is 08692092. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Eksperimental'naya i Klinicheskaya Farmakologiya is cited by a total of 55 articles during the last 3 years (Preceding 2022).


Eksperimental'naya i Klinicheskaya Farmakologiya Impact IF 2022-2023


The Impact IF 2022 of Eksperimental'naya i Klinicheskaya Farmakologiya is 0.25, which is computed in 2023 as per its definition. Eksperimental'naya i Klinicheskaya Farmakologiya IF is increased by a factor of 0.03 and approximate percentage change is 13.64% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Eksperimental'naya i Klinicheskaya Farmakologiya Impact IF 2023 Prediction


Impact IF 2022 of Eksperimental'naya i Klinicheskaya Farmakologiya is 0.25. If the same upward trend persists, Impact IF may rise in 2023 as well.


Impact IF Trend


Year wise Impact IF of Eksperimental'naya i Klinicheskaya Farmakologiya. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 0.25
2021 0.22
2020 0.28
2019 0.19
2018 0.16
2017 0.18
2016 0.11
2015 0.16
2014 0.15

Eksperimental'naya i Klinicheskaya Farmakologiya h-index


  Table Setting

Eksperimental'naya i Klinicheskaya Farmakologiya has an h-index of 16. It means 16 articles of this journal have more than 16 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Eksperimental'naya i Klinicheskaya Farmakologiya ISSN


The ISSN of Eksperimental'naya i Klinicheskaya Farmakologiya is 08692092. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Eksperimental'naya i Klinicheskaya Farmakologiya Rank and SCImago Journal Rank (SJR)


The overall rank of Eksperimental'naya i Klinicheskaya Farmakologiya is 24566. According to SCImago Journal Rank (SJR), this journal is ranked 0.116. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Eksperimental'naya i Klinicheskaya Farmakologiya by Year


Year SJR
2023/2024 Coming Soon
2022 0.116
2021 0.116
2020 0.112
2019 0.107
2018 0.116
2017 0.121
2016 0.113
2015 0.135
2014 0.142

Ranking of Eksperimental'naya i Klinicheskaya Farmakologiya by Year


Year Ranking
2023/2024 Coming Soon
2022 24566
2021 23659
2020 28199
2019 26860
2018 25942
2017 25129
2016 26438
2015 22540
2014 21390

Eksperimental'naya i Klinicheskaya Farmakologiya Publisher


Table Setting

Eksperimental'naya i Klinicheskaya Farmakologiya is published by Folium Ltd. It's publishing house is located in Russian Federation. Coverage history of this journal is as following: 1992-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Eksperimental'naya i Klinicheskaya Farmakologiya is Eksp. Klin. Farmakol.. This abbreviation ('Eksp. Klin. Farmakol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Eksperimental'naya i Klinicheskaya Farmakologiya


If your research field is/are related to Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Eksperimental'naya i Klinicheskaya Farmakologiya?

Eksperimental'naya i Klinicheskaya Farmakologiya latest impact IF is 0.25. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 0.28 (2020) and 0.11 (2016), respectively, in the last 9 years. Moreover, its average IS is 0.19 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Eksperimental'naya i Klinicheskaya Farmakologiya?

The Eksperimental'naya i Klinicheskaya Farmakologiya has an SJR (SCImago Journal Rank) of 0.116, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.142 in 2014 and the lowest being 0.107 in 2019. Furthermore, the average SJR of the Eksperimental'naya i Klinicheskaya Farmakologiya over the previous 9-year period stands at 0.19.


What's the latest h-index of the Eksperimental'naya i Klinicheskaya Farmakologiya?

The latest h-index of the Eksperimental'naya i Klinicheskaya Farmakologiya is 16.


Who's the publisher of the Eksperimental'naya i Klinicheskaya Farmakologiya?

The Eksperimental'naya i Klinicheskaya Farmakologiya is published by the Folium Ltd, with its country of publication being the Russian Federation.


What's the current ranking of the Eksperimental'naya i Klinicheskaya Farmakologiya?

The Eksperimental'naya i Klinicheskaya Farmakologiya is currently ranked 24566 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 21390 in 2014 and its lowest position of 28199 in 2020.


What's the abbreviation or short name for the Eksperimental'naya i Klinicheskaya Farmakologiya?

The standard ISO4 abbreviation for the Eksperimental'naya i Klinicheskaya Farmakologiya is Eksp. Klin. Farmakol..


Is the "Eksperimental'naya i Klinicheskaya Farmakologiya" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Eksperimental'naya i Klinicheskaya Farmakologiya is classified as a journal that the Folium Ltd publishes.


What's the scope or major areas of the Eksperimental'naya i Klinicheskaya Farmakologiya?

The Eksperimental'naya i Klinicheskaya Farmakologiya encompasses the following areas:

  • Medicine (miscellaneous)
  • Pharmacology
  • Toxicology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Eksperimental'naya i Klinicheskaya Farmakologiya?

The Eksperimental'naya i Klinicheskaya Farmakologiya is assigned the following International Standard Serial Numbers (ISSN): 08692092.


What's the best quartile of the Eksperimental'naya i Klinicheskaya Farmakologiya?

The best quartile for the Eksperimental'naya i Klinicheskaya Farmakologiya is Q4 (2022).


What's the coverage history of the Eksperimental'naya i Klinicheskaya Farmakologiya?

The Eksperimental'naya i Klinicheskaya Farmakologiya coverage history can be summarized as follows: 1992-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Zeitschrift fur Germanistische Linguistik journal 22945 De Gruyter Mouton 15 0.19
Journal of Geriatric Physical Therapy journal 5578 Lippincott Williams and Wilkins Ltd. 43 1.80
Istanbul University - Journal of Electrical and Electronics Engineering journal 24654 University of Istanbul 0 0.00
Milan Journal of Mathematics journal 3120 Birkhauser Verlag Basel 28 1.79
Journal of Applied Business Research journal 23890 29 0.28
Modern Language Journal journal 918 Wiley-Blackwell 103 3.89
Metascience journal 13645 Springer Nature 3 0.13
Brazilian Symposium of Computer Graphic and Image Processing conference and proceedings 16004 32 0.00
Physica Status Solidi - Rapid Research Letters journal 6699 Wiley-VCH Verlag 76 2.77
Asian Nursing Research journal 7629 Elsevier BV 35 2.31

Check complete list




Year wise Impact Score (IS) of Eksperimental'naya i Klinicheskaya Farmakologiya

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.25
2021 0.22
2020 0.28
2019 0.19
2018 0.16
2017 0.18
2016 0.11
2015 0.16
2014 0.15



Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

See All

Top Journals/Conferences in Toxicology

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

MMWR. Surveillance summaries : Morbidity and mortality weekly report. Surveillance summaries / CDC
Centers for Disease Control and Prevention (CDC) | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Environmental Science and Technology Letters
American Chemical Society | United States

Journal of Hazardous Materials
Elsevier | Netherlands

Acta Pharmaceutica Sinica B
Elsevier BV | Netherlands

Theranostics
Ivyspring International Publisher | Australia

Environmental Health Perspectives
Public Health Services, US Dept of Health and Human Services | United States

See All